Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 70, Issue 5, Pages (November 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life  Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Volume 63, Issue 5, Pages (May 2013)
Global Trends in Testicular Cancer Incidence and Mortality
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 72, Issue 5, Pages (November 2017)
A Sealed Laparoscopic Nephroureterectomy: A New Technique
Volume 64, Issue 4, Pages (October 2013)
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Volume 45, Issue 4, Pages (April 2004)
Volume 64, Issue 4, Pages (October 2013)
John P. Mulhall, Francesco Montorsi  European Urology 
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 64, Issue 4, Pages (October 2013)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 4, Pages (October 2015)
Volume 59, Issue 3, Pages (March 2011)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Volume 51, Issue 3, Pages (March 2007)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 64, Issue 4, Pages (October 2013)
Volume 70, Issue 1, Pages (July 2016)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 48, Issue 4, Pages (October 2005)
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Trends in Hypospadias Surgery: Results of a Worldwide Survey
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.
The Economic Costs of Overactive Bladder in Germany
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 51, Issue 1, Pages (January 2007)
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Testicular Cancer Variations in Time and Space in Europe
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Volume 72, Issue 5, Pages (November 2017)
European Urology is “Your” Journal
The Start-Up of the Platinum Journal: A Fascinating Challenge
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Volume 4, Issue 5, Pages 2-3 (October 2006)
Economic Burden of Bladder Cancer Across the European Union
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Virology: a scientific discipline facing new challenges
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Epidemiology and Demographics of Prostatitis
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi, Gerald B. Brock  European Urology  Volume 52, Issue 4, Pages 990-1005 (October 2007) DOI: 10.1016/j.eururo.2007.06.048 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Primary clinical indications for daily PDE5-I regimens. European Urology 2007 52, 990-1005DOI: (10.1016/j.eururo.2007.06.048) Copyright © 2007 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.